Clinical Trials
72 trialsPeople With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Mammo'C
University Hospital, Montpellier
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
National Cancer Institute (NCI)
LIVERAL
ANRS, Emerging Infectious Diseases
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
University of Chicago
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Singlera Genomics Inc.
Mondelta
Hospices Civils de Lyon
MHALT
University of California, San Francisco
OUTREACH2
Mina Alpha Limited
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
St. Louis University
MATCHES
H. Lee Moffitt Cancer Center and Research Institute
VERYMARKERS
Centro di Riferimento Oncologico - Aviano
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
ELITE
Helio Genomics
CLOVER
University of California, Davis
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy
Ain Shams University
RCT
Alexandria University
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Meridian Bioscience, Inc.
OMNI-Can
OMNI Medical Services, LLC
ECHAPS
University Hospital, Grenoble
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Direct Acting Antiviral-Post Authorization Safety Study
Target PharmaSolutions, Inc.
Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening
University of La Laguna
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
University of Texas Southwestern Medical Center
HEPCASUS
Karolinska Institutet
Association of Hepatitis C Virus With Breast Cancer
Mansoura University
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
HATCHeT
Bayside Health
STOP-HCC
University of Texas Southwestern Medical Center
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Gilead Sciences
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
Cairo University
The Second Multicenter Hemophilia Cohort Study
National Institutes of Health Clinical Center (CC)
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
A2ALL-2
Arbor Research Collaborative for Health
Optimal
University of Texas Southwestern Medical Center
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Austral University, Argentina
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine